Favorable Outcome of Severe Acute Hepatitis B in a Patient Treated with Antithrombin III and Antiviral Therapy

被引：4
作者：
Chalupa, Pavel [1 ]
Holub, Michal
机构：
[1] Univ Hosp Bulovka, Dept Infect & Trop Dis 3, CZ-18081 Prague 8, Czech Republic
来源：
CLINICAL INFECTIOUS DISEASES | 2009年 / 49卷 / 03期
关键词：
LAMIVUDINE;
D O I：
10.1086/600822
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：481 / 481
页数：1
相关论文
共 3 条
[1]   Lamivudine treatment for acute severe hepatitis B: a pilot study [J].
Schmilovitz-Weiss, H ;
Ben-Ari, Z ;
Sikuler, E ;
Zuckerman, E ;
Sbeit, W ;
Ackerman, Z ;
Safadi, R ;
Lurie, Y ;
Rosner, G ;
Tur-Kaspa, R ;
Reshef, R .
LIVER INTERNATIONAL, 2004, 24 (06) :547-551
[2]   Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience [J].
Tillmann, HL ;
Hadem, J ;
Leifeld, L ;
Zachou, K ;
Canbay, A ;
Eisenbach, C ;
Graziadei, I ;
Encke, J ;
Schmidt, H ;
Vogel, W ;
Schneider, A ;
Spengler, U ;
Gerken, G ;
Dalekos, GN ;
Wedemeyer, H ;
Manns, MP .
JOURNAL OF VIRAL HEPATITIS, 2006, 13 (04) :256-263
[3]   High-dose a randomized antithrombin III in severe sepsis -: A randomized controlled trial [J].
Warren, BL ;
Eid, A ;
Singer, P ;
Pillay, SS ;
Carl, P ;
Novak, I ;
Chalupa, P ;
Atherstone, A ;
Pénzes, I ;
Kübler, A ;
Knaub, S ;
Keinecke, HO ;
Heinrichs, H ;
Schindel, F ;
Juers, M ;
Bone, RC ;
Opal, SM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (15) :1869-1878
1